Awardee OrganizationUNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Description
Abstract Text
DESCRIPTION (provided by applicant): Vacuolar H+ATPases (V-ATPases or H+ATPases) are highly conserved proton pumps that couple hydrolysis of ATP to proton transport out of the cytosol. They are essential for renal acid-base homeostasis, for sorting of newly synthesized proteins in the Golgi, and for acidification and normal function of the yeast vacuole. Although a central question in the field is how V-ATPase is regulated under physiological conditions, until recently little was known about the underlying mechanisms. The glycolytic enzyme aldolase has been identified to interact with three subunits of V-ATPase by our lab. This represents the first example of physical association between the ATP-generating glycolytic pathway and an ATP-hydrolyzing ion pump. Deletion of the aldolase gene in yeast cells results in complete disassembly of and a dramatic reduction in V-ATPase. These abnormalities can be fully restored by aldolase complementation. Our data suggest that disruption of the interaction between aldolase and V-ATPase results in malfunction of V-ATPase, which leads to renal tubular acidosis found in patients with hereditary fructose intolerance, an autosomal recessive disorder caused by mutations in an isoform of aldolase. In this proposal, we will carry out molecular genetic analysis in yeast cells to examine the structural basis and regulation of the interaction between aldolase and V-ATPase, and test the hypothesis that aldolase mediates V-ATPase assembly, function and stability. The specific aims of this proposal are: 1) to generate aldolase and V-ATPase subunit mutants that lack binding for a specific interaction but retain aldolase enzymatic activity and/or binding to other V-ATPase subunits; 2) to express the aldolase and V-ATPase subunit mutants in yeast deletion mutant strains lacking either aldolase or a single subunit of V-ATPase, and examine the effects on V-ATPase assembly, function and stability; 3) to examine the parameters required for aldolase to bind intact V-ATPase and disassembled V-ATPase sectors. These studies will provide important insight into the molecular basis for metabolic control of proton transport.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
SDS polyacrylamide gel electrophoresisadenosinetriphosphatasealdehyde lyaseautoradiographychemical stabilitydensitometryenzyme activityfungal geneticsgene deletion mutationimmunoprecipitationmembrane transport proteinsmolecular assembly /self assemblynucleic acid sequenceprotein protein interactionprotein structure functionprotein transportsite directed mutagenesisvesicle /vacuoleyeast two hybrid system
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
849
DUNS Number
094878337
UEI
KMH5K9V7S518
Project Start Date
30-September-2003
Project End Date
30-June-2006
Budget Start Date
01-July-2004
Budget End Date
30-June-2006
Project Funding Information for 2004
Total Funding
$151,500
Direct Costs
$100,000
Indirect Costs
$51,500
Year
Funding IC
FY Total Cost by IC
2004
National Institute of Diabetes and Digestive and Kidney Diseases
$151,500
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R21DK064977-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R21DK064977-02
Patents
No Patents information available for 5R21DK064977-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R21DK064977-02
Clinical Studies
No Clinical Studies information available for 5R21DK064977-02
News and More
Related News Releases
No news release information available for 5R21DK064977-02
History
No Historical information available for 5R21DK064977-02
Similar Projects
No Similar Projects information available for 5R21DK064977-02